There are specific things in our written submission.
I think you need to try to do your best to ensure that freedom of information and access to information rules apply to the new model that this bill is trying to build for pharmacare. Ensure that there's accountability, so the Auditor General of Canada can go in and do value-for-money audits.
There should be a new function of an ombudsman, so that people who think the system has not responded to them in a fair and reasonable way have an ability to access, without going to court, a review and oversight function. Those officers and the health minister should be required to report back to Parliament on a regular basis on steps, progress, problems and alternatives.